Zynfuse
Zynfuse
The global orthopedic implant market is witnessing a paradigm shift, with Titanium Bone Screws remaining the cornerstone of surgical fixation. Valued at over USD 5.8 Billion in 2023, the market for bone screws is projected to grow at a CAGR of 6.2% through 2030. This growth is fueled by an aging global population, the rising prevalence of osteoporosis, and the increasing demand for minimally invasive surgery (MIS).
Dominant players in the USA and Europe set the benchmark for quality, but Asian manufacturers like Zynfuse Medical are closing the gap with high-precision manufacturing and competitive pricing.
While Grade 5 Titanium (Ti6Al4V) is the industry standard due to its Biocompatibility and modulus of elasticity, there is a surge in demand for Type II Anodized surfaces to improve fatigue strength.
The "China-Plus-One" strategy is reshaping medical device sourcing, making reliable suppliers with ISO 13485 certification and FDA/CE marks critical for global distributors.
Choosing a supplier requires evaluating E-E-A-T: Experience in clinical outcomes, Expertise in metallurgy, Authority in the surgical community, and Trustworthiness in lead times.
Industry leader with the widest range of AO-standard screws. Known for the "Synthes" gold standard in trauma.
Pioneers in advanced locking technology and specialized plating systems for complex fractures.
Focused on high-performance titanium alloys and extensive digital surgery integration.
Dominates the spinal screw segment with the CD Horizon and Solera systems.
Specializes in bone fusion and high-precision orthopedic implants with 12 years of clinical engineering experience.
Leading innovators in joint reconstruction and specialized sports medicine anchors.
Renowned for anatomical plating and unique compression screw designs for small bone fractures.
A fast-growing force in robotic-assisted spinal screw placement.
Experts in external fixation and bio-stimulative bone growth solutions.
German engineering excellence with a focus on surgical instrumentation and implant longevity.
Zynfuse Medical Technology Co., Ltd. is a professional orthopedic medical device manufacturer specializing in bone fusion and advanced implant systems. Since 2016, we have bridged the gap between complex surgical needs and manufacturing precision.
Modern Facility
Industry Experience
R&D Engineers
Global Partners
Annual New Products
We provide full documentation for MDEL (Canada), TGA (Australia), and CE (Europe). Our systems are rooted in ISO 13485:2016 quality management standards.
From custom thread pitches for osteoporotic bone to specialized head geometries for low-profile plating, our 85 engineers handle rapid prototyping.
Every batch undergoes mechanical performance testing, fatigue analysis, and cytotoxicity evaluation to ensure 0% rejection rates in clinical settings.
The future of titanium bone screws lies in Bio-interactive surfaces. Zynfuse is currently researching:
Grade 4 is pure titanium, offering excellent corrosion resistance but lower strength. Grade 5 (Ti6Al4V) is an alloy with significantly higher tensile strength, making it ideal for load-bearing bone screws in trauma and spinal surgery.
We utilize Swiss-type lathes and 2D automatic video measuring instruments to maintain tolerances within ±0.01mm, ensuring optimal pull-out strength and surgical safety.
Yes, Titanium is non-ferromagnetic. While it may cause minor artifacts, it is generally considered safe for patients undergoing MRI scans compared to stainless steel implants.
Absolutely. We offer double-sterile packaging and customized labeling to meet the localization requirements of hospital procurement departments worldwide.
